After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

Active management after concussion is the best way for patients to recover and get back to school and work as quickly as ...

BOSTON - About 75 North Atlantic right whales, representing about 20% of the critically endangered species' population worldwide, have gathered in an area off the coast of New England. A aerial ...

From 1971 to 1983, he lived in the west-end neighbourhood of Laurier Heights, shovelling walks for spending money, delivering the Edmonton Journal and graduating from St. Francis Xavier high ...

After a search and seizure of her apartment, Rodriguez-Lopez was arrested by search warrant on Jan. 9 and charged with reckless endangerment and practicing medicine without a license. New Haven ...

A quantitative alcohol history should be recorded for all patients, because alcohol use contributes to many physical and mental disorders. A person-centered, nonjudgmental approach should be ...

Panel A summarizes the conventional model of how oncogenic RAS guanosine triphosphatases (i.e., Kirsten rat sarcoma viral oncogene homologue [KRAS], neuroblastoma RAS viral oncogene homologue ...

with no new safety signals. Seven-year invasive disease–free survival was 80.8% with adjuvant T-DM1 and 67.1% with adjuvant trastuzumab, for an absolute difference of 13.7 percentage points.

Carpal tunnel syndrome affects 87 men and 192 women per 100,000 population worldwide. 1 Common signs include paresthesia, pain, and weakness in the median nerve distribution of the hand.

A new morphometric fracture occurred in 22 women (6.3%) in the zoledronate–zoledronate group, in 23 women (6.6%) in the zoledronate–placebo group, and in 39 women (11.1%) in the placebo ...